Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Changes in Stockholders Equity

v3.21.2
Consolidated Statements of Changes in Stockholders Equity - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2019 $ 1,194 $ 32,218,643 $ (176,717) $ (23,241,835) $ 8,801,285
Shares, Issued, Beginning Balance at Dec. 31, 2019 11,949,042        
Shares issued on conversion of convertible debentures $ 12 395,241 395,253
Shares issued on conversion of convertible debentures, shares 123,399        
Common stock issued to settle deferred purchase consideration $ 21 842,411 842,432
Common stock issued to settle deferred purchase consideration, shares 204,437        
Stock based compensation expense 118,818 118,818
Foreign currency translation adjustment (112,030) (112,030)
Net loss 157,609 157,609
Ending balance, value at Mar. 31, 2020 $ 1,227 33,575,113 (288,747) (23,084,226) 10,203,367
Shares, Issued, Ending Balance at Mar. 31, 2020 12,276,878        
Shares issued on conversion of convertible debentures $ 11 333,074 333,085
Shares issued on conversion of convertible debentures, shares 103,586        
Common stock issued to settle deferred purchase consideration $ 11 273,736 273,747
Common stock issued to settle deferred purchase consideration, shares 114,538        
Stock based compensation expense 79,971 79,971
Fair value of warrants issued on convertible debt extensions 719,390 719,390
Foreign currency translation adjustment 18,516 18,516
Net loss (2,525,555) (2,525,555)
Ending balance, value at Jun. 30, 2020 $ 1,249 34,981,284 (270,231) (25,609,781) 9,102,521
Shares, Issued, Ending Balance at Jun. 30, 2020 12,495,002        
Shares issued on conversion of convertible debentures   10,666 10,666
Shares issued on conversion of convertible debentures, shares 3,341        
Common stock issued to settle deferred purchase consideration $ 4 91,261 91,265
Common stock issued to settle deferred purchase consideration, shares 35,130        
Stock based compensation expense 45,301 45,301
Public offering proceeds $ 417 10,005,832 10,006,249
Public offering proceeds, shares 4,166,666        
Expenses related to public offering 1,040,127 1,040,127
Foreign currency translation adjustment 218,193 218,193
Net loss (1,213,281) (1,213,281)
Expenses related to public offering (1,040,127) (1,040,127)
Ending balance, value at Sep. 30, 2020 $ 1,670 44,094,217 (52,038) (26,823,062) 17,220,787
Shares, Issued, Ending Balance at Sep. 30, 2020 16,700,139        
Beginning balance, value at Dec. 31, 2020 $ 2,003 53,064,919 267,948 (33,178,517) 20,156,353
Shares, Issued, Beginning Balance at Dec. 31, 2020 20,029,834        
Proceeds from warrants exercised $ 149 3,909,832 3,909,981
Proceeds from warrants exercised 1,488,809        
Common stock issued to settle liabilities $ 47 2,676,854 2,676,901
Common stock issued to settle liabilities, Shares 467,990        
Restricted stock awards $ 2 139,998 140,000
Restricted stock awards, Shares 24,476        
Stock based compensation expense 288,968 288,968
Foreign currency translation adjustment (344,088) (344,088)
Net loss (609,579) (609,579)
Ending balance, value at Mar. 31, 2021 $ 2,201 60,080,571 (76,140) (33,788,096) 26,218,536
Shares, Issued, Ending Balance at Mar. 31, 2021 22,011,109        
Proceeds from warrants exercised $ 1 12,499 12,500
Proceeds from warrants exercised 5,000        
Stock based compensation expense 291,162 291,162
Foreign currency translation adjustment 84,743 84,743
Net loss (2,771,350) (2,771,350)
Ending balance, value at Jun. 30, 2021 $ 2,202 60,384,232 8,603 (36,559,446) 23,835,591
Shares, Issued, Ending Balance at Jun. 30, 2021 22,016,109        
Shares issued in consideration of acquisition $ 127 4,544,177 4,544,304
Shares issued in consideration of acquisition, shares 1,265,823        
Proceeds from warrants exercised $ 1 39,999 40,000
Proceeds from warrants exercised 16,000        
Stock based compensation expense 671,678 671,678
Foreign currency translation adjustment (154,572) (154,572)
Net loss (3,515,177) (3,515,177)
Ending balance, value at Sep. 30, 2021 $ 2,330 $ 65,640,086 $ (145,969) $ (40,074,623) $ 25,421,824
Shares, Issued, Ending Balance at Sep. 30, 2021 23,297,932